Vaccine News and Research

Latest Vaccine News and Research

Free licences of European patents on the hereditary breast cancer gene BRCA2

The Institute of Cancer Research and Cancer Research Technology Limited, the technology transfer company of the charity Cancer Research UK, today announced the availability of free licences of European patents on the hereditary breast cancer gene BRCA2 to publicly funded research laboratories and not-for-profit research laboratories.

11 Aug 2004

Changes to the UK's childhood vaccination programme

From the end of September these vaccines will be given in the routine vaccination schedule in a combined vaccine along with Diphtheria, Tetanus, and Hib.

9 Aug 2004

Austrian researchers in a world first have successfully engineered an allergy vaccine

Austrian researchers in a world first have successfully engineered an allergy vaccine using a genetically modified version of the birch pollen allergen.

9 Aug 2004

The British government has announced plans for a new combined vaccination for babies and children

The British government has announced plans for a new combined vaccination for babies and children. A single jab will protect children against diphtheria, tetanus, pertussis (whooping cough), Haemophilus influenzae type B (Hib), and polio.

9 Aug 2004

Reminder to avoid handling bats for risk of rabies

In the wake of an increase in calls reporting human and pet contacts with bats, the Washington Department of Health has reminded people that avoiding bats can protect them from rabies. Bats are not aggressive animals and they generally do not intentionally attack humans.

9 Aug 2004

Self-recovery from Hep C infection linked to genes that suppress action of killer immune cells

In a study to be published in Science online Aug. 6, researchers at Johns Hopkins have found that genes involved in suppressing the body's defensive "killer" immune cells are a potential key factor in spontaneous recovery from hepatitis C.

5 Aug 2004

Mayo Clinic and IBM have announced a broad collaboration to accelerate advances in patient care and research

Mayo Clinic and IBM have announced a broad collaboration to accelerate advances in patient care and research with an aggressive set of technology initiatives. The goal is to take advantage of an explosion in new medical data to drive tighter linkage between research and the practice of medicine to achieve breakthroughs.

5 Aug 2004

Potential of genomics in disease research yet to be realized

Over the past decade genomics has revolutionized our understanding of how microorganisms cause disease. However, genomic studies need to be extended to a more diverse array of microorganisms and research tools improved to gain additional insights into pathogenesis, according to a new report released by the American Academy of Microbiology.

5 Aug 2004

Experimental vaccine against ricin

Scientists have developed an experimental vaccine against ricin, a potential biological threat agent, which fully protected mice from aerosol challenge with lethal doses of the toxin.

5 Aug 2004

Aventis ships its influenza vaccine, Fluzone

Aventis began to ship its influenza vaccine (Fluzone(R), Influenza Virus Vaccine) today, meeting the company's goal to provide Fluzone vaccine to customers to allow health-care providers to plan successful immunization programs for the upcoming influenza season.

3 Aug 2004

Determining the age of female mosquitoes may be crucial to halting the spread of diseases like malaria

A recent project at The Queensland Institute of Medical Research, Australia found that determining the age of female mosquitoes may be crucial to halting the spread of diseases like malaria that kill 2 million people annually.

2 Aug 2004

New approach to cancer vaccines may eradicate skin cancer tumors

Mayo Clinic and British researchers have developed a new approach to cancer vaccines that purposely kills healthy skin cells to target the immune system against tumors. The new approach has eradicated skin cancer tumors in mice.

2 Aug 2004

America's childhood immunization rates are at record high levels

The U. S. Department of Health and Human Services has announced that the nation's childhood immunization rates are at record high levels, including significant increases in rates of immunization for chickenpox and pneumococcal pneumonia, the two most recent additions to the childhood immunization schedule.

2 Aug 2004

New glycan arrays discover autoimmunogenic activities of SARS-CoV

Researchers in New York City and Guangzhou, China applied the rapidly-developing carbohydrate microarray technology to study an inactivated SARS-coronavirus (SARS-CoV) vaccine and discovered autoimmunogenic activity of this newly identified human viral pathogen.

2 Aug 2004

Philadelphia diet drug trial completed

Wyeth has announced that the jury in the case of Rhonda Istnick and Henry Clepper v. Wyeth, et al. rendered its decision, finding in favor of the Company in the case brought by Ms. Istnick, while awarding Mr. Clepper compensatory damages in the amount of $48,000.

29 Jul 2004

Researchers have shown that an experimental vaccine can reduce the amount of neurodegeneration in a mouse model for Parkinson's disease

The finding suggests that a similar therapy might eventually be able to slow the devastating course of Parkinson's disease in humans.

29 Jul 2004

Breakthrough discovery on Leishmaniasis, world's most deadly tropical diseases

Scientists at the Liverpool School of Tropical Medicine, working with colleagues at the University of Dundee, have discovered how the tiny sand fly spreads one of the world's most deadly tropical diseases - Leishmaniasis.

29 Jul 2004

Tetanus protection requires booster shots every 10 years, starting in adolescence

As the final weeks of summer dwindle away, parents are scurrying to provide their kids with all the books, supplies and sports equipment needed to meet this year's upcoming academic and athletic challenges.

29 Jul 2004

New process that simplifies the production of proteins

F. William Studier, a biophysicist at the U.S. Department of Energy's Brookhaven National Laboratory, has won a 2004 R&D 100 award for developing a new process that simplifies the production of proteins in the widely used T7 gene expression system.

29 Jul 2004

Eradicating deadly E. coli O157:H7 from the bottoms of cows may prevent future outbreaks of food poisoning

According to an article in the August 2004 issue Microbiology Today, the quarterly magazine of the Society for General Microbiology, the majority of people with E. coli O157:H7, picked up the infection from cattle, either through direct contact with faeces or by consuming contaminated meat or milk.

28 Jul 2004

Vaccine News and Research

Latest Vaccine News and Research

Free licences of European patents on the hereditary breast cancer gene BRCA2

Changes to the UK's childhood vaccination programme

Austrian researchers in a world first have successfully engineered an allergy vaccine

The British government has announced plans for a new combined vaccination for babies and children

Reminder to avoid handling bats for risk of rabies

Self-recovery from Hep C infection linked to genes that suppress action of killer immune cells

Mayo Clinic and IBM have announced a broad collaboration to accelerate advances in patient care and research

Potential of genomics in disease research yet to be realized

Experimental vaccine against ricin

Aventis ships its influenza vaccine, Fluzone

Determining the age of female mosquitoes may be crucial to halting the spread of diseases like malaria

New approach to cancer vaccines may eradicate skin cancer tumors

America's childhood immunization rates are at record high levels

New glycan arrays discover autoimmunogenic activities of SARS-CoV

Philadelphia diet drug trial completed

Researchers have shown that an experimental vaccine can reduce the amount of neurodegeneration in a mouse model for Parkinson's disease

Breakthrough discovery on Leishmaniasis, world's most deadly tropical diseases

Tetanus protection requires booster shots every 10 years, starting in adolescence

New process that simplifies the production of proteins

Eradicating deadly E. coli O157:H7 from the bottoms of cows may prevent future outbreaks of food poisoning

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Vaccine News and Research

Latest Vaccine News and Research

Changing the landscape of R&D to build clinical success from the ground up

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Newsletters you may be interested in